I think the "interim results" from CD16 on critical patients was stated by Nader to be expected in Mid to end of August, and anticipated acceptable p value at that time. I've never heard what the Primary Endpoint is for Brazil CD16? Who knows what it is? Have they started enrollment yet? Probably....I'd think.
We need a Cytodyn executive to join our IH board here.